Hims & Hers Health Inc
HIMS37.090USD
-0.690-1.83%
Close 11/25, 16:00（ET）Quotes delayed by 15 min
8.44BMarket Cap
63.07P/E TTM
More Details of Hims & Hers Health Inc Company
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. It offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. It offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.
Hims & Hers Health Inc Info
Ticker SymbolHIMS
Company nameHims & Hers Health Inc
IPO dateSep 09, 2019
CEOMr. Andrew Dudum
Number of employees1637
Security typeOrdinary Share
Fiscal year-endSep 09
Address2269 Chestnut St
CitySAN FRANCISCO
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code94123
Phone14158510195
Websitehttps://www.forhims.com/
Ticker SymbolHIMS
IPO dateSep 09, 2019
CEOMr. Andrew Dudum
Company Executives of Hims & Hers Health Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.43M
-0.03%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
155.86K
-1.66%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
77.03K
--
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
36.56K
+37.31%
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
+72.64%
Mr. Mo Elshenawy
Mr. Mo Elshenawy
Chief Technology Officer
Chief Technology Officer
--
--
Mr. David Wells
Mr. David Wells
Lead Independent Director
Lead Independent Director
--
--
Dr. Delos Cosgrove, M.D.
Dr. Delos Cosgrove, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher D. Payne
Mr. Christopher D. Payne
Independent Director
Independent Director
--
--
Dr. Patrick Carroll, M.D.
Dr. Patrick Carroll, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.43M
-0.03%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
155.86K
-1.66%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
77.03K
--
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
36.56K
+37.31%
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
+72.64%
Mr. Mo Elshenawy
Mr. Mo Elshenawy
Chief Technology Officer
Chief Technology Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
By BusinessUSD
Name
Revenue
Proportion
Online
536.88M
98.54%
Wholesale
7.95M
1.46%
By RegionUSD
Name
Revenue
Proportion
United States
544.83M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Online
536.88M
98.54%
Wholesale
7.95M
1.46%
Shareholding Stats
Updated: Sat, Nov 15
Updated: Sat, Nov 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
10.07%
The Vanguard Group, Inc.
8.88%
Capital World Investors
8.57%
JP Morgan Asset Management
5.87%
Farallon Capital Management, L.L.C.
4.90%
Other
61.71%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
10.07%
The Vanguard Group, Inc.
8.88%
Capital World Investors
8.57%
JP Morgan Asset Management
5.87%
Farallon Capital Management, L.L.C.
4.90%
Other
61.71%
Shareholder Types
Shareholders
Proportion
Investment Advisor
53.13%
Investment Advisor/Hedge Fund
13.33%
Research Firm
12.70%
Hedge Fund
10.85%
Individual Investor
6.32%
Pension Fund
1.80%
Bank and Trust
1.45%
Sovereign Wealth Fund
0.74%
Private Equity
0.23%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
970
195.39M
89.11%
-889.66K
2025Q2
893
201.00M
92.37%
-34.62M
2025Q1
847
185.19M
85.97%
-48.88M
2024Q4
739
195.19M
91.41%
-9.62M
2024Q3
627
167.49M
80.36%
-35.34M
2024Q2
588
165.89M
79.48%
-12.74M
2024Q1
503
156.70M
75.98%
-10.05M
2023Q4
463
153.90M
75.37%
-26.71M
2023Q3
444
160.41M
78.97%
-33.55M
2023Q2
426
173.15M
85.66%
-3.29M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
21.67M
9.96%
-124.92K
-0.57%
Jun 30, 2025
The Vanguard Group, Inc.
18.63M
8.56%
+192.76K
+1.05%
Jun 30, 2025
Capital World Investors
18.56M
8.53%
+17.99M
+3131.84%
Jun 30, 2025
Farallon Capital Management, L.L.C.
8.21M
3.77%
+259.88K
+3.27%
Jun 30, 2025
Dudum (Andrew)
9.43M
4.33%
+5.79K
+0.06%
Sep 17, 2025
Renaissance Technologies LLC
6.87M
3.16%
-154.90K
-2.21%
Jun 30, 2025
Goldman Sachs & Company, Inc.
7.54M
3.47%
-175.36K
-2.27%
Jun 30, 2025
State Street Investment Management (US)
7.04M
3.24%
-402.35K
-5.41%
Jun 30, 2025
Morgan Stanley & Co. LLC
4.05M
1.86%
+517.63K
+14.65%
Jun 30, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
YieldMax Ultra Option Income Strategy ETF
4.87%
Fidelity Digital Health ETF
3.63%
Invesco S&P MidCap 400 Pure Growth ETF
3.07%
SPDR S&P Health Care Services ETF
2.25%
Invesco S&P MidCap 400 GARP ETF
2.06%
iShares U.S. Healthcare Providers ETF
1.91%
Invesco S&P MidCap Momentum ETF
1.82%
Invesco S&P MidCap Quality ETF
1.79%
Invesco Dorsey Wright Momentum ETF
1.69%
Franklin US Small Cap Multifactor Index ETF
0.97%
View more
YieldMax Ultra Option Income Strategy ETF
Proportion4.87%
Fidelity Digital Health ETF
Proportion3.63%
Invesco S&P MidCap 400 Pure Growth ETF
Proportion3.07%
SPDR S&P Health Care Services ETF
Proportion2.25%
Invesco S&P MidCap 400 GARP ETF
Proportion2.06%
iShares U.S. Healthcare Providers ETF
Proportion1.91%
Invesco S&P MidCap Momentum ETF
Proportion1.82%
Invesco S&P MidCap Quality ETF
Proportion1.79%
Invesco Dorsey Wright Momentum ETF
Proportion1.69%
Franklin US Small Cap Multifactor Index ETF
Proportion0.97%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Hims & Hers Health Inc?
The top five shareholders of Hims & Hers Health Inc are:
BlackRock Institutional Trust Company, N.A. holds 21.67M shares, accounting for 9.96% of the total shares.
The Vanguard Group, Inc. holds 18.63M shares, accounting for 8.56% of the total shares.
Capital World Investors holds 18.56M shares, accounting for 8.53% of the total shares.
Farallon Capital Management, L.L.C. holds 8.21M shares, accounting for 3.77% of the total shares.
Dudum (Andrew) holds 9.43M shares, accounting for 4.33% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 21.67M shares, accounting for 9.96% of the total shares.
The Vanguard Group, Inc. holds 18.63M shares, accounting for 8.56% of the total shares.
Capital World Investors holds 18.56M shares, accounting for 8.53% of the total shares.
Farallon Capital Management, L.L.C. holds 8.21M shares, accounting for 3.77% of the total shares.
Dudum (Andrew) holds 9.43M shares, accounting for 4.33% of the total shares.
What are the top three shareholder types of Hims & Hers Health Inc?
The top three shareholder types of Hims & Hers Health Inc are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Capital World Investors
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Capital World Investors
How many institutions hold shares of Hims & Hers Health Inc (HIMS)?
As of 2025Q3, 970 institutions hold shares of Hims & Hers Health Inc, with a combined market value of approximately 195.39M, accounting for 89.11% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -3.26%.
What is the biggest source of revenue for Hims & Hers Health Inc?
In FY2025Q2, the Online business generated the highest revenue for Hims & Hers Health Inc, amounting to 536.88M and accounting for 98.54% of total revenue.
